• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性主导的预防艾滋病毒性传播的方法。

Female-controlled methods to prevent sexual transmission of HIV.

作者信息

Elias C J, Coggins C

机构信息

Population Council, Bangkok, Thailand.

出版信息

AIDS. 1996 Dec;10 Suppl 3:S43-51.

PMID:8970711
Abstract

UNLABELLED

THE NEED FOR PREVENTION: Women throughout the world face a growing risk of infection with HIV. Consistent condom use, one cornerstone of primary prevention strategy, is not always feasible for many women. Consequently, women urgently need infection prevention technology that is within their personal control.

METHODS

This session will review current efforts to develop and test female-controlled methods for preventing sexual transmission of HIV and other sexually transmitted pathogens. Both physical and chemical methods will be summarized, including recent findings concerning the efficacy and acceptability of the vaginal pouch (female condom), as well as an overview of research on vaginal microbicides. Data from studies of existing over-the-counter spermicides will be reviewed. The wide range of novel microbicidal products currently being evaluated in the laboratory and early clinical trials demonstrate the breadth of possibilities presented by chemical barrier methods. However, formidible challenges face public and private sector research and development efforts. This session will conclude by highlighting several issues related to the clinical evaluation and introduction of female-controlled prevention technology.

摘要

未加标注

预防的必要性:世界各地的女性感染艾滋病毒的风险日益增加。坚持使用避孕套作为一级预防策略的基石之一,对许多女性来说并不总是可行的。因此,女性迫切需要能够由她们自己掌控的感染预防技术。

方法

本次会议将回顾目前为开发和测试女性可控的预防艾滋病毒及其他性传播病原体性传播方法所做的努力。将对物理和化学方法进行总结,包括有关阴道套(女用避孕套)有效性和可接受性的最新研究结果,以及阴道杀菌剂的研究概述。将回顾现有非处方杀精剂的研究数据。目前正在实验室和早期临床试验中评估的各种新型杀菌产品表明了化学屏障方法所展现的广泛可能性。然而,公共和私营部门的研发工作面临着巨大挑战。本次会议将通过强调与女性可控预防技术的临床评估和引入相关的几个问题来结束。

相似文献

1
Female-controlled methods to prevent sexual transmission of HIV.女性主导的预防艾滋病毒性传播的方法。
AIDS. 1996 Dec;10 Suppl 3:S43-51.
2
Vaginal contraceptives: worldwide use remains low but methods have potential.阴道避孕法:全球使用率仍然较低,但这些方法具有潜力。
Netw Res Triangle Park N C. 1986 Winter;7(2):1, 5.
3
Spermicides for family planning and disease protection: an update.用于计划生育和疾病防护的杀精剂:最新进展
Netw Res Triangle Park N C. 1991 Dec;12(3):23-6.
4
Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda.乌干达西南部女性对避孕套及女性主导的预防艾滋病毒和性传播感染保护措施的态度。
AIDS Care. 1999 Dec;11(6):687-98. doi: 10.1080/09540129947596.
5
[Contraceptives, HIV, and other sexually transmitted diseases].[避孕药、艾滋病毒及其他性传播疾病]
Ginecol Obstet Mex. 1995 Jan;63:40-5.
6
New spermicide: FHI developing propranolol.新型杀精剂:FHI正在研发普萘洛尔。
Netw Res Triangle Park N C. 1986 Winter;7(2):2-3.
7
The dual goals of reproductive health.生殖健康的双重目标。
Netw Res Triangle Park N C. 1996 Spring;16(3):3 p.
8
Preventing HIV transmission in "priority" countries.在“重点”国家预防艾滋病毒传播。
Netw Res Triangle Park N C. 1993 May;13(4):18-21.
9
Clients at STD risk need barrier methods.有性传播疾病风险的客户需要屏障避孕法。
Netw Res Triangle Park N C. 1994 May;14(4):11-7.
10
Seeking HIV prevention strategies for women.
Netw Res Triangle Park N C. 1993 May;13(4):9-11.

引用本文的文献

1
Health care providers' attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe.肯尼亚、南非和津巴布韦的卫生保健提供者对为少女和年轻女性提供口服 PrEP 的态度和经验。
BMC Health Serv Res. 2021 Oct 18;21(1):1112. doi: 10.1186/s12913-021-06978-0.
2
Female Condom Use and Its Acceptability Among HIV-serodiscordant Couples in China.中国 HIV 血清不一致夫妇中女用避孕套的使用及其可接受性。
J Assoc Nurses AIDS Care. 2019 Jul-Aug;30(4):428-439. doi: 10.1097/JNC.0000000000000004.
3
Differences in the ability to predict and prepare for sexual activity between HIV-infected and HIV-uninfected young South African Women.
感染艾滋病毒和未感染艾滋病毒的南非年轻女性在预测和准备性行为方面的能力差异。
J AIDS HIV Res. 2018;10(1). doi: 10.5897/JAHR2017.0455. Epub 2018 Jan 31.
4
Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.从荚膜-阴道环局部递送富马酸替诺福韦二吡呋酯和恩曲他滨可保护猕猴免受多次猴-人免疫缺陷病毒暴露感染。
PLoS One. 2016 Jun 8;11(6):e0157061. doi: 10.1371/journal.pone.0157061. eCollection 2016.
5
Microbicides for the Treatment of Sexually Transmitted HIV Infections.用于治疗性传播艾滋病毒感染的杀微生物剂。
J Pharm (Cairo). 2014;2014:352425. doi: 10.1155/2014/352425. Epub 2014 Feb 12.
6
Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.参与达匹韦林阴道环预防HIV-1随机临床试验的女性特征。
PLoS One. 2015 Jun 10;10(6):e0128857. doi: 10.1371/journal.pone.0128857. eCollection 2015.
7
Measuring self-efficacy to use vaginal microbicides: the Microbicide Use Self-Efficacy instrument.测量使用阴道杀菌剂的自我效能:杀菌剂使用自我效能量表。
Sex Health. 2013 Aug;10(4):339-47. doi: 10.1071/SH13013.
8
Partially hidden Markov model for time-varying principal stratification in HIV prevention trials.用于艾滋病预防试验中时变主要分层的部分隐藏马尔可夫模型。
J Am Stat Assoc. 2012 Mar 1;107(497):52-65. doi: 10.1080/01621459.2011.643743.
9
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda.在乌干达西南部农村地区开展的一项 III 期临床试验(MDP 301)中,艾滋病毒 1 型血清不一致的夫妇长期持续使用阴道杀微生物凝胶。
Trials. 2013 Feb 1;14:33. doi: 10.1186/1745-6215-14-33.
10
An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.评价改善印度安得拉邦安慰剂凝胶试验中依从性报告的方法。
AIDS Behav. 2013 Jul;17(6):2222-36. doi: 10.1007/s10461-012-0402-z.